Authors

Robert Tindle

PhD, Emeritus Professor in Immunology, University of Queensland, Faculty of Science, Brisbane, Qld; Director (Retired), Sir Albert Sakzewski Virus Research Centre, Royal Children’s Hospital, Brisbane, Qld; Director, Clinical Medical Virology Centre, University of Queensland, Brisbane, Qld

Long COVID: Sufferers can take heart

This article acknowledges the increased knowledge, acceptance and awareness of long COVID but emphasises the need for more guidance on handling and diagnosing long COVID and supporting patients.


Tumour-agnostic immunotherapy for rare and uncommon cancers: The patient’s dilemma

This viewpoint discusses immune checkpoint inhibitor (ICI) drugs for the treatment of rare and less common cancers.